CODX | Co-Diagnostics, Inc.

Index- P/E- EPS (ttm)-1.06 Insider Own0.90% Shs Outstand30.26M Perf Week-4.59%
Market Cap31.49M Forward P/E- EPS next Y-0.79 Insider Trans1.11% Shs Float29.75M Perf Month-20.91%
Income-31.70M PEG- EPS next Q-0.23 Inst Own21.00% Short Float / Ratio2.43% / 5.02 Perf Quarter-63.64%
Sales12.10M P/S2.60 EPS this Y-136.90% Inst Trans-15.08% Short Interest0.72M Perf Half Y-64.01%
Book/sh3.75 P/B0.28 EPS next Y11.20% ROA-23.10% Target Price4.67 Perf Year-81.19%
Cash/sh2.49 P/C0.42 EPS next 5Y- ROE-25.10% 52W Range0.98 - 7.13 Perf YTD-58.73%
Dividend- P/FCF- EPS past 5Y6.60% ROI-12.60% 52W High-85.41% Beta-0.64
Dividend %- Quick Ratio22.30 Sales past 5Y437.00% Gross Margin77.70% 52W Low6.67% ATR0.08
Employees145 Current Ratio23.80 Sales Q/Q-97.40% Oper. Margin- RSI (14)28.48 Volatility6.65% 7.02%
OptionableYes Debt/Eq0.00 EPS Q/Q-157.80% Profit Margin- Rel Volume0.78 Prev Close1.07
ShortableYes LT Debt/Eq0.00 EarningsMay 11 AMC Payout- Avg Volume144.00K Price1.04
Recom2.70 SMA20-13.37% SMA50-22.62% SMA200-59.66% Volume113,032 Change-2.80%
Date Action Analyst Rating Change Price Target Change
Aug-12-22Downgrade Sidoti Buy → Neutral $5
Dec-29-21Initiated Sidoti Buy $14
Mar-29-21Downgrade Maxim Group Buy → Hold
May-20-20Upgrade Maxim Group Hold → Buy
May-18-20Reiterated H.C. Wainwright Buy $20 → $35
Mar-09-20Reiterated H.C. Wainwright Buy $4 → $20
Mar-03-20Downgrade Maxim Group Buy → Hold
May-18-23 07:21AM
May-11-23 05:25PM
May-09-23 09:30AM
May-05-23 10:35AM
09:30AM Loading…
Apr-26-23 09:30AM
Apr-13-23 09:30AM
Mar-23-23 09:26AM
Mar-21-23 09:39AM
Mar-20-23 10:46PM
Mar-17-23 09:30AM
Mar-16-23 05:45PM
Mar-09-23 09:30AM
09:30AM Loading…
Mar-02-23 09:30AM
Feb-28-23 12:11PM
Feb-22-23 09:30AM
Feb-02-23 09:30AM
Jan-24-23 09:30AM
Jan-05-23 09:30AM
Dec-03-22 07:25AM
Nov-30-22 10:00AM
Nov-16-22 05:17AM
Nov-14-22 09:30AM
Nov-12-22 07:34AM
Nov-10-22 04:13PM
Nov-03-22 02:41PM
Nov-01-22 09:30AM
Oct-27-22 09:30AM
09:30AM Loading…
Oct-26-22 09:30AM
Oct-19-22 09:30AM
Oct-14-22 08:41AM
Sep-27-22 06:00AM
Sep-14-22 09:30AM
Sep-12-22 09:30AM
Aug-31-22 09:30AM
Aug-22-22 11:30AM
Aug-15-22 06:03PM
Aug-12-22 07:17AM
Aug-11-22 04:01PM
Aug-09-22 05:09PM
Aug-07-22 09:19AM
Jul-27-22 09:30AM
Jul-26-22 09:30AM
Jul-20-22 09:30AM
Jul-11-22 11:44AM
Jul-05-22 11:19AM
Jun-28-22 09:30AM
Jun-24-22 06:00AM
Jun-15-22 09:30AM
Jun-14-22 02:45PM
Jun-09-22 09:30AM
May-26-22 06:01PM
May-19-22 09:30AM
May-12-22 04:01PM
May-07-22 08:14AM
May-03-22 09:30AM
Apr-28-22 09:30AM
Apr-22-22 09:30AM
Apr-19-22 09:30AM
Apr-14-22 10:01AM
Mar-25-22 07:03PM
Mar-24-22 04:01PM
Mar-22-22 09:30AM
Mar-17-22 09:30AM
Mar-16-22 02:30AM
Mar-15-22 01:15PM
Mar-14-22 09:30AM
Feb-28-22 01:02PM
Feb-17-22 09:30AM
Feb-10-22 09:30AM
Feb-03-22 09:30AM
Jan-21-22 09:30AM
Jan-13-22 09:30AM
Jan-10-22 06:30AM
Dec-31-21 09:30AM
Dec-30-21 10:24AM
Dec-28-21 05:38AM
Dec-27-21 04:21PM
Dec-22-21 09:25AM
Dec-13-21 04:18PM
Dec-07-21 04:00PM
Dec-06-21 11:54AM
Nov-29-21 08:00AM
Nov-15-21 11:30AM
Nov-12-21 05:26PM
Nov-11-21 04:01PM
Nov-04-21 09:38AM
Nov-03-21 06:40AM
Oct-28-21 12:00PM
Oct-13-21 08:00AM
Oct-06-21 10:54AM
Sep-27-21 09:30AM
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Brian LeeChief Financial OfficerMar 20Buy1.903,0005,69776,236Mar 21 05:13 PM